Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a Post-market Clinical Follow-up Study. It will verify the long-term safety and performance of the Infinity-Lock Button System (ILBS) when used for acute and chronic dislocations of the Acromioclavicular Joint and used as described by the manufacturer's instructions.
This is a Post-market Clinical Follow-up Study. It will verify the long-term safety and performance of the Infinity-Lock Button System (ILBS) when used for acute and chronic dislocations of the Acromioclavicular Joint and used as described by the manufacturer's instructions.
The medical device (ILBS) in this study is already on the market and is manufactured by Xiros Ltd.
The ILBS comprises of a polyester flexible tubular tape and a titanium button. The tape is used to secure the joint and the button is used to secure the tape into position.
This study will collect data on patients who meet the entry criteria and receive the device; it will recruit patients from several clinical sites.
All patients in the study will receive the ILBS, as it is a single armed study. The total length of the study is expected to be 4.5 years; this includes a recruitment period of approximately 18 months and a 3-year follow-up.
A total of 58 subjects will be enrolled into the study. Follow up is at 3 months, 6 months, 1,2 and 3 years.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Infinity-Lockâ„¢ Button System | Participants diagnosed with acute or chronic Grade Ill-VI ACJ dislocation who require treatment with an Infinity-Lock Button System who meet the inclusion criteria and none of the exclusion criteria. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Infinity-Lock Button System | Device | Infinity-Lock Button System |
|
| Measure | Description | Time Frame |
|---|---|---|
| Constant Murley Score (CMS) | The primary performance endpoint is the change in the CMS from baseline to 1 year after surgery. Minimum score is 0 maximum is 100 with the better functioning shoulders having a greater number of points. | 1 year |
| Device Related or Procedure Related Adverse events | device-related and/or procedure-related adverse events up to 1 year after surgery. | 1 year |
| Measure | Description | Time Frame |
|---|---|---|
| Constant Murley Score (CMS) | Change from baseline CMS and subscale scores (pain, activities of daily living, strength and ROM) at each timepoint up to 3 years after surgery. Minimum score is 0 maximum is 100 with the better functioning shoulders having a greater number of points. | 3 years |
| American Shoulder and Elbow Surgeons Score (ASES) |
Not provided
Inclusion Criteria:
Patient must be 16 years old or above.
Exclusion criteria.
Not provided
Not provided
Not provided
Grade III-VI ACJ Dislocations.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Lisa Cook | Contact | +44 (0) 113 238 7200 | lisa.cook@xiros.co.uk | |
| Vikki Adams | Contact | 07825626018 | vikki.adams@xiros.co.uk |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| East Kent Hospitals University NHS Foundation Trust, | Recruiting | Canterbury | United Kingdom | |||
No plan to share IDP
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Change from baseline American Shoulder and Elbow Surgeons (ASES) Score at each timepoint up to 3 years after surgery. Total score 0-100 ASES points, 0 = worse pain and functional loss/disability. |
| 3 years |
| RAND Short Form 36 (SF-36) V1 | Change from baseline RAND Short Form 36 (SF-36) V1 Quality of Life Health Survey at each timepoint up to 3 years after surgery.The RAND SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. | 3 years |
| Nottingham Clavicle Score (NCS) | Change from baseline Nottingham Clavicle Score (NCS) at each timepoint up to 3 years after surgery. Maximum score of 100 (fewest difficulties) and a minimum score of 20 (most difficulties) | 3 years |
| Ability to perform normal daily work and normal recreational activities | This is a subscale of the CMS and is a measurement of how much of the normal daily work or recreational activity the patient is able to perform. The scale is a line which will be marked by the subject, it will be reported as 0-100% with 100% meaning they are able to perform 100% of their normal daily work or recreational activity | 3 years |
| coracoclavicular distance | Change from baseline CC distance using the anteroposterior (AP) X-ray (Zanca view) at each timepoint up to 1 year after surgery. | 1 year |
| Device-related and/or procedure-related adverse events | Device-related and/or procedure-related adverse events up to 3 years after surgery. | 3 years |
| Barts Health NHS Trust |
| Recruiting |
| London |
| E1 1FR |
| United Kingdom |
| Nottingham University Hospitals | Recruiting | Nottingham | NG7 2UH | United Kingdom |
| Royal Berkshire NHS Foundation Trust | Active, not recruiting | Reading | RG1 5AN | United Kingdom |
| ID | Term |
|---|---|
| D004204 | Joint Dislocations |
| ID | Term |
|---|---|
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
| D014947 | Wounds and Injuries |
Not provided
Not provided